UDG Healthcare Public Limited Co. Notice of Q1 2018 Trading Update (2825B)
January 09 2018 - 2:00AM
UK Regulatory
TIDMUDG
RNS Number : 2825B
UDG Healthcare Public Limited Co.
09 January 2018
9 January 2018
UDG Healthcare plc
Notice of Q1 2018 Trading Update
UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading
international healthcare services provider, will issue a trading
update for the first quarter to 31 December 2017 at 7.00 a.m. (GMT)
on Tuesday, 30 January 2018.
The Company will also host a conference call for investors and
analysts at 9.00am (GMT) on Tuesday, 30 January 2018 to discuss the
statement. The dial-in details are as follows:
Standard International +44 (0) 20 3003
Access 2666
------------------------ ----------------
UK Toll Free 0808 109 0700
------------------------ ----------------
+353 (0) 1 436
Ireland 0959
------------------------ ----------------
Password UDG
------------------------ ----------------
A playback facility will be available for seven days on +44 (0)
20 8196 1998. The access code for the replay will be 8908246#.
For further information, please contact:
Keith Byrne
Head of Investor Relations, Strategy & Corporate
Communications
UDG Healthcare plc
Tel: +353-1-468-9000
Lisa Kavanagh / Jack Hickey / Isabelle Saber
Powerscourt
Tel: +44-207-250-1446
Email: udghealthcare@powerscourt-group.com
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner
of choice delivering advisory, commercial, clinical, communications
and packaging services to the healthcare industry, employing over
9,000 people with operations in 24 countries and delivering
services in over 50 countries.
UDG Healthcare plc operates across three divisions: Ashfield,
Sharp and Aquilant.
Ashfield is a global leader in commercialisation services for
the pharmaceutical and healthcare industry, operating across three
broad areas of activity: advisory, communications and commercial
& clinical services. It focuses on supporting healthcare
professionals and patients at all stages of the product life cycle.
The division provides field and contact centre sales teams,
healthcare communications, patient support, audit, advisory,
medical information and event management services to over 300
healthcare companies.
Sharp is a global leader in contract commercial packaging and
clinical trial packaging services for the pharmaceutical and
biotechnology industries, operating from state-of-the-art
facilities in the US and Europe.
Aquilant is a leading provider of outsourced sales, marketing,
distribution and engineering services to the medical and scientific
sectors in the UK, Ireland and the Netherlands.
The company is listed on the London Stock Exchange and is a
constituent of the FTSE 250.
For more information, please go to: www.udghealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORBPMRTMBAMBLP
(END) Dow Jones Newswires
January 09, 2018 02:00 ET (07:00 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024